Recent News
FDA Official Key to Actemra Approval Now Working for Drug Maker He Regulated
The U.S. Food & Drug Administration (FDA) maintains that its rules and federal law prevent agency employees from leveraging their positions in the private sector. However, a report recently published by Science Magazine suggests this may not actually be the … Continue reading
Joint Status Report Outlines Progress of Federal Taxotere Hair Loss Lawsuits
Federally-filed Taxotere lawsuits involving the chemotherapy drug’s alleged potential to cause permanent hair loss continue to move forward in the U.S. District Court, Eastern District of Louisiana. The litigation convened its most recent status conference on July 18th. A day … Continue reading
Gadolinium MRI Contrast Dye Lawsuit Alleges Toxic Effects from MultiHance and OptiMark
A California man has joined the growing litigation over MRI contrast dyes and the risks allegedly associated with gadolinium retention. Plaintiff Alleges Severe Health Consequences from Gadolinium Retention According to a complaint filed in the U.S. District Court, Northern District … Continue reading
IVC Filters Associated with Higher Death Risk Among VTE Patients
Inferior Vena Cava (IVC) filters may not be the best treatment option for patients who suffer from venous thromboembolism, or VTE, according to a new study which suggests a higher risk of 30-day mortality among those who receive the filters. … Continue reading
Diabetes Drug Lawsuit Filings Climb, Following Reinstatement of Pancreatic Cancer Litigation
Hundreds of additional plaintiffs are now pursuing diabetes drug lawsuits, following the reinstatement of pancreatic cancer claims involving Byetta, Victoza, and other incretin mimetics, by an appeals court late last year. Incretin Mimetics and Pancreatic Cancer Byetta and other incretin … Continue reading
Research Suggests Cancer Risk Increases with Chronic Proton Pump Inhibitor Use
Chronic users of Nexium and other proton pump inhibitors may face a higher risk of cancer, according to findings recently published by a team of Swedish researchers. Proton pump inhibitors, including prescription and over-the-counter versions of Nexium, Prilosec, and Prevacid, … Continue reading
Report: SIRVA Cited in Half of New Vaccine Injury Lawsuits
Incidents of SIRVA, or Shoulder Injury Resulting from Vaccine Administration, may be on the rise, as half of all vaccine injury claims filed with the federal government last year involved this painful and potentially debilitating complication. What is SIRVA? SIRVA … Continue reading
Janssen Discontinued Levaquin Production as Concerns Over Fluoroquinolone Side Effects Grow
Johnson & Johnson’s Janssen Pharmaceuticals unit discontinued production of Levaquin in December 2017, amid growing concerns over the serious side effects and complications potentially associated with the use of fluoroquinolone antibiotics. The decision affected both oral and injectable versions of … Continue reading
Colgate-Palmolive Settles Another Talcum Powder Cancer Lawsuit
Colgate-Palmolive has agreed to settle another mesothelioma lawsuit involving the company’s talcum powder products. The agreement to resolve the case was announced yesterday, just before the talcum powder lawsuit was set to go to trial in California Superior Court in … Continue reading
Transvaginal Mesh Complications Lead to Virtual Ban at U.K. Hospitals
Regulators in the U.K. have effectively banned the use of transvaginal mesh in hospitals run by the National Health Services (NHS) in an effort to lessen the risk “life-changing and life-threatening injuries” to women. Decision a Major Victory for U.K. … Continue reading
Follow Us
